Alexandersen P, Karsdal MA, Christiansen C.
Long-term prevention with hormone-replacement therapy after the menopause:which women should be targeted?
Womens Health (London UK) 2009; 5(6): 637-647.

Bjarnason NH,  Nielsen TF,  Jørgensen, HL,  Christiansen C .
The influence of smoking on bone loss and response to nasal estradiol.
Climacteric  2009; 12(1): 59-65.

Bay-Jensen AC, Tabassi NC, Søndergaard LV, Andersen TL, Dagnaes-Hansen F, Garnero P, Kassem M, Delaisse JM.
The response to estrogen deprivation on cartilage collagen degradation markers; CTX-II is unique compared to other markers of collagen turnover.
Arthritis Res Ther 2009;11(1): R9.

Charni-Ben Tabassi N, Richardot P, Toh L, Marotte H, Bay-Jensen AC, Miossec P, Garnero P.
Circulating nitrated N-telopeptide of type III Collagen (IIINys) as a biochemical marker of oxidative-related synovial tissue metabolism in rheumatoid arthritis.
Ann Rheum Dis 2009; 68(3) 451-452.

Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Ried IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C (Freedam Trial.)
Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
N Engl J Med 2009; 361(8): 756-765.

Dam EB, Byrjalsen I, Karsdal MA, Qvist P, Christiansen C.
Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 month by MRI.
Osteoarthritis & Cartilage 2009; 17: 384-389.

Dam EB, Loog M, Christiansen C, Byrjalsen I, Folkesson J, Nielsen M, Qazi AA, Pettersen PC, Garnero P, Karsdal MA.
Identification of progressors in osteoarthritis by combining biochemical and MRI based markers.
Arthritis Res Ther 2009; 11(4): R 115.

Fernandes CE, Zerbini C, Russo LA, Albernaz MA, Eis SR, Szejnfeld VL, Pompei LM.
Effects of short-term risedronate on bone resorption and patient satisfaction in postmenopausal osteoporosis patients.
J Clin Densitom 2009; 12(1): 77-83.

Garnero P.
Bone markers in osteoporosis.
Curr Osteoporos Rep 2009; 7(3): 84-90.

Glover SJ, Gall M, Schoenborn-Kellenberger O, Wagener M, Garnero P, Boonen S, Cauley JA, Block DM, Delmas PD, Eastell R.
Establishing a reference interval for bone turnover markers in 637 healthy, young, premenopausal women from the United Kingdom, France, Belgium, and the United States.
J Bone Min Res 2009; 24: 389-397.

Glover SJ, Eastell R, McCloskey EV, Rogers A, Garnero P, Lowery J, Belleli R, Writht TM, John MR.
Rapid and robust response of biochemical markers of bone formation to teriparatide therapy.
Bone 2009; 45(6): 1053-1058.

Henriksen DB, Alexandersen P, Hartmann B,  Adrian CL, Byrjalsen I, Bone HG, Holst JJ,  Christiansen C.
Four-month treatment with GLP2 significantly increases hip BMD. A randomized placebo-controlled, dose-ranging study in postmenopausal women with low BMD.
Bone 2009; 45(5): 833-842.

Henriksen K, Gram J,  Neutzsky-Wulff AV, Jensen VK,  Dziegiel  MH, Bollerslev J, Karsdal MA.
Characterization of acid flux in osteoclasts from patients harboring a G215R mutation in  CIC-7.
Biochem Biophys Res Common 2009; 378(4): 804-809.

Henriksen K, Neutzsky-Wulff AV, Bonewald LF, Karsdal MA.
Local communication on and within bone controls bone remodelling.
Bone 2009; 44: 1026-1033.

Henriksen K, Byrjalsen I, Nielsen RH, Madsen AN, Larsen LK, Christiansen C, Beck-Nielsen H, Karsdal MA.
A comparison of glycemic control, water retention, and musculoskeletal effects of balaglitazone and pioglitazone in diet-induced obese rats.
Eur J Pharmacol 2009; 616: 340-345.

Hoeck HC, Li B, Qvist P.
Changes in 25-Hydroxyvitamin D3 to oral treatment with vitamin D3 in postmenopausal females with osteoporosis.
Osteoporosis Int 2009; 20: 1329-1335.

Karsdal MA, Byrjalsen I, Henriksen K, Riis BJ, Christiansen C.
A pharmacokinetic and pharmacodynamic comparison of synthetic and recombinant oral salmon calcitonin.
J Clin Pharmacol 2009; 49(2): 229-234.

Karsdal MA, Henriksen K, Leeming DJ, Mitchell P, Duffin K, Barascuk N, Klickstein L, Aggarwal  P, Nemirovskiy O, Byrjalsen I, Qvist P, Bay-Jensen AC, Dam EB, Madsen SH, Christiansen C.
Biochemical markers and the FDA critical path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development.
Biomarkers 2009; 14(3): 181-202.

Karsdal MA, Byrjalsen I, Azria M, Arnold M, Choi L, Riis BJ, Christiansen C.
Influence of food intake on the bioavailability and efficacy of oral calcitonin.
Br J Clin Pharmacol 2009; 67(4): 413-420.

Leeming DJ, Henriksen K, Byrjalsen I, Qvist P, Madsen SH, Garnero P, Karsdal MA.
Is bone quality associated with collagen age?
Osteoporosis Int 2009; 20: 1461-1470.

Li  B,  Byrjalsen I,  Glendenning P,  Henriksen DB,  Hoeck HC, Taranto M, Vasikaran S,  Fraser WD, Christiansen C, Qvist P.
Selective monitoring of vitamin D2 and D3 supplementation with a highly specific 25-hydroxyvitamin D3 immunoassay with negligible cross-reactivity to 25- hydroxyvitamin D2.
Clin Chim Acta 2009; 404(2):144-148.

Madsen SH, Søndergaard BC, Jensen AC, Karsdal MA.
Cartilage formation measured by a novel PIINP assay suggests that IGF-I does not stimulate but maintains cartilage formation ex vivo.
Scand J Rheumatol 2009; 38(3): 222-226.

Nielsen M, Raundahl J, Pettersen PC, Loog M, Karemore G, Karsdal MA, Christiansen C.
Low-dose transdermal estradiol induces breast density and heterogeneity changes comparable to those of raloxifene.
Menopause 2009; 16(4): 785-791.

Ovesen J, Møller-Madsen B, Nielsen PT, Christensen PH, Simonsen O, Hoeck HC, Laursen MB, Thomsen JS.
Differences in zinc status between patients with osteoarthritis and osteoporosis.
J Trace Elem Med Biol 2009; 23(1): 1-8.

Rasmussen H,  Bagger Y,  Tanko LB, Christiansen C, Werge T.
Lack of association of the serotonin transporter gene promoter region polymorphism, 5-HTTLPR, including rs 25531 with cigarette smoking and alcohol consumption.
Am J Med Gen B Neuropsychiat 2009; 150B(4): 575-580.

Richardot P,  Charni-Ben Tabassi N, Toh L, Marotte H,  Bay-Jensen AC,  Miossec P, Garnelo P.
Nitrated type III collagen as a biological markers of nitric oxide-mediated synovial tissue metabolism in osteoarthritis.
Osteoarthritis Cartilage 2009; 17(10): 1362-1367.

Rozenberg S, Pornel B, Koninckx PR, Palacios S, Christiansen C.
Endometrium protection and acceptability of nasally administered continuously combined hormone therapy: a multicentre, multinational, double-blind trial in postmenopausal women evaluating three regimens of 17 β-estradiol and norethisterone when compared with an orally administered 17β-estradiol norethisterone regimen.
Hum Reprod. 2009; 24(7): 1739-1747.

Segovia-Silvestre T,  Neutzsky-Wulff AV,  Sørensen MG, Christiansen, C,  Bollerslev J,  Karsdal MA, Henriksen K.
Advances in osteoclast biology resulting from the study of osteoporotic mutations.
Hum Genet  2009; 124(6): 561-577.

Schaefers M, Muysers C, Alexandersen P, Christiansen C.
Effect of microdose transdermal 17-beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomised double-blind trial.
Menopause 2009; 16(3): 559-565.

Styrkardottir U m.fl.+CC, PA.
New sequence variants associated with bone mineral density.
Nat Genet 2009; 41(1): 15-17.

Sulem P  mfl. CC+ PA.
Genome-wide association study identifies sequence variants on 6q21 associated with age at menarche.
Nature Genet 2009; vol 41(6): 734-738.

Thorleifsson G mfl. CC + PA.
Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density.
Nat Genet 2009; 41(8): 926-930.

Voorzanger-Rousselot N, Journe F, Doriath V, Body JJ, Garnero P.
Assessment of Circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases.
Calcif Tissue Int 2009; 83: 348-354.

Voorzanger-Rousselot N, Ben-Tabassi NC, Garnero P.
Opposite relationships between circulating Dkk-1 and cartilage breakdown in patients with rheumatoid arthritis and knee osteoarthritis.
Ann Rheum Dis 2009; 68(9): 1513-1514.